This GE HealthCare Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Author: Avi Kapoor | March 11, 2025 07:15am
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Baird analyst David George upgraded the rating for Capital One Financial Corporation (NYSE:COF) from Neutral to Outperform and raised the price target from $190 to $200. Capital One Finl shares closed at $163.87 on Monday. See how other analysts view this stock.
B of A Securities analyst Tazeen Ahmad upgraded PTC Therapeutics, Inc. (NASDAQ:PTCT) from Underperform to Neutral and raised the price target from $41 to $55. PTC Therapeutics shares closed at $52.49 on Monday. See how other analysts view this stock.
Goldman Sachs analyst David Roman upgraded the rating for GE HealthCare Technologies Inc. (NASDAQ:GEHC) from Neutral to Buy and boosted the price target from $85 to $100. GE HealthCare shares closed at $85.36 on Monday. See how other analysts view this stock.
Evercore ISI Group analyst Durgesh Chopra upgraded CenterPoint Energy, Inc. (NYSE:CNP) from In-Line to Outperform and raised the price target from $36 to $37. CenterPoint Energy shares closed at $34.43 on Monday. See how other analysts view this stock.
Wolfe Research analyst Peter Supino upgraded the rating for Madison Square Garden Entertainment Corp. (NYSE:MSGE) from Peer Perform to Outperform and announced a $46 price target. Madison Square Garden shares closed at $30.59 on Monday. See how other analysts view this stock.
Considering buying GEHC stock? Here’s what analysts think:
